300290.SHE Bringspring Science and Tech
- Market cap
- CNY 3.43B
- P/E
- -
- P/B
- 5.75x
- ROE
- -41.6%
- Dividend yield
- 0.05%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300290.SHE undervalued?
Graham numberThe Graham number of Bringspring Science and Tech cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Bringspring Science and Tech fundamental analysis
No fundamental analysis for Bringspring Science and Tech yet.
Bringspring Science and Tech stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Bringspring Science and Tech
Bringspring Science and Technology Co., Ltd. engages in the smart healthcare business in China. It operates through Health Care and Social Security, Government and Public Utilities, and Others segments. The company offers medical record statistics, medical record tracing, digital medical records, and paperless medical record management; smart healthcare solutions for core clinical scenarios; and clinical information system construction and upgrades for emergency care, includ…
Full company profileBringspring Science and Tech financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Bringspring Science and Tech annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 503M | 419M | 627M | 724M | 788M | 817M | 705M | 798M | 767M | 755M | 525M |
| Gross Profit | 160M | 128M | 223M | 271M | 301M | 235M | 229M | 346M | 298M | 300M | 184M |
| Operating Income | 60.3M | 23.0M | 55.3M | 72.8M | 95.9M | -52.7M | -32.1M | 88.4M | 23.8M | 22.0M | -57.9M |
| EBITDA | - | 37.7M | 53.9M | 82.0M | 133M | -304M | -182M | 81.2M | 43.5M | 3.45M | -230M |
| Net Income | 32.4M | 18.8M | 20.4M | 43.2M | 80.4M | -405M | -225M | 26.5M | -2.92M | -45.1M | -239M |
| EPS | - | 0.04 | 0.04 | 0.08 | 0.13 | -0.63 | -0.35 | 0.04 | 0.00 | -0.07 | -0.37 |
| Balance Sheet | |||||||||||
| Total Assets | 1.11B | 1.05B | 1.47B | 1.60B | 1.98B | 1.87B | 1.53B | 1.51B | 1.52B | 1.55B | 1.47B |
| Total Liabilities | 208M | 345M | 579M | 502M | 572M | 791M | 666M | 623M | 624M | 716M | 827M |
| Shareholders' Equity | 882M | 710M | 890M | 1.09B | 1.37B | 1.04B | 810M | 826M | 822M | 763M | 574M |
| Cash & Short-term Investments | 267M | 187M | 196M | 286M | 384M | 415M | 290M | 276M | 218M | 146M | 118M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 49.3M | 18.7M | 95.1M | 80.3M | 114M | 455K | 23.6M | 53.2M | -25.0M | -47.1M | - |
| Capital Expenditure | 50.0M | 41.3M | 19.6M | 30.9M | 30.9M | 63.4M | 48.5M | 19.5M | 19.2M | 26.5M | 13.9M |
| Free Cash Flow | - | -22.6M | 75.5M | 49.4M | 83.0M | -63.0M | -24.9M | 33.7M | -44.2M | -73.6M | -142M |
| Ratios | |||||||||||
| ROE | 3.7% | 2.7% | 2.3% | 4.0% | 5.9% | -39.0% | -27.8% | 3.2% | -0.4% | -5.9% | -41.6% |
| ROA | 2.9% | 1.8% | 1.4% | 2.7% | 4.1% | -21.6% | -14.7% | 1.8% | -0.2% | -2.9% | -16.3% |
| Net Profit Margin | 6.4% | 4.5% | 3.3% | 6.0% | 10.2% | -49.5% | -31.9% | 3.3% | -0.4% | -6.0% | -45.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Bringspring Science and Tech dividends
- Dividend yield
- 0.05%
- Forward dividend
- 0.02 CNY
- Payout ratio
- -
- Ex-dividend date
- Jul 10, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 1.55M | 0.00 | - |
| 2024 | CNY 659K | 0.00 | - |
| 2023 | CNY 2.08M | 0.00 | 7.8% |
| 2022 | CNY 4.55M | 0.01 | - |
| 2021 | CNY 24.3M | 0.04 | - |
| 2020 | CNY 18.0M | 0.03 | 22.5% |
| 2019 | CNY 13.9M | 0.03 | 32.3% |
| 2018 | CNY 11.5M | 0.02 | 56.5% |
| 2017 | CNY 11.1M | 0.02 | 58.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.5:1 on Jun 6, 2019.
Who owns Bringspring Science and Tech
- Insiders 1.45%
- Institutions 22.01%
- Public & others 76.54%
- Shares outstanding 640M
- Free float 502M
Bringspring Science and Tech company profile
- Company name
- Bringspring Science and Tech
- Ticker
- 300290.SHE
- ISIN
- CNE100001C30
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Feb 16, 2012
- Sector
- Technology
- Industry
- IT Services
- Employees
- 1,387
- Fiscal year end
- December
- Address
- No. 7A3, Kaifa Road, Shenyang, China, 110027
- Phone
- 86 24 2285 1050
- Website
- bringspring.com
About Bringspring Science and Tech
Bringspring Science and Technology Co., Ltd. engages in the smart healthcare business in China. It operates through Health Care and Social Security, Government and Public Utilities, and Others segments. The company offers medical record statistics, medical record tracing, digital medical records, and paperless medical record management; smart healthcare solutions for core clinical scenarios; and clinical information system construction and upgrades for emergency care, including triage and emergency records, electronic medical record generation, RFID smart wristbands, smart queuing, and emergency assistance, as well as ICU and perioperative digital platforms, including IoT-based ICU monitoring and clinical data services with predictive models, and anesthesia systems for risk assessment, intraoperative monitoring, and postoperative follow-up. It also offers triage guidance, waiting-information push, in-clinic workflows, and post-diagnosis health education; IoT-connected real-time clinical data collection and intelligent analysis; and remote ICU visits, surgical education support, and AI-assisted intelligent nursing robots with video monitoring and early warning. The company provides data quality control, DRG/DIP data support, BI reporting, automated data collection and testing, and Rongjia Houqin, a smart logistics platform for equipment, energy, sewage, emergency, and logistics management; builds regional healthcare and medical insurance platforms for government agencies, supporting DRG/DIP supervision, intelligent auditing, medical insurance cost control, medical quality control, digital medical record management, and 5G-enabled regional emergency medical services; and smart medical insurance, digital HR/social security, long-term care insurance, medical insurance checks, digital grid solutions, hybrid cloud operations, IT maintenance, zero-trust security, scanning, and database AI auditing. The company was founded in 2005 and is headquartered in Shenyang, China.
Bringspring Science and Tech management
6- Mr. Gongxue WangPresident · born 1976
- Ms. Yan ZhaoFinancial Director · born 1973
- Mr. Yuan ZhouSecretary · born 1985
- Mr. Bin LiuVice President · born 1979
- Mr. Zhi Chao LiVice President · born 1984
- Mr. Jingjing ZhangAccounting Supervisor · born 1975